Brian Lenihan Jnr (Dublin West, Fianna Fail)

I thank Senator Morrissey for raising this matter on the Adjournment. MRSA is a significant infection which occurs in hospitals and in the community. It is a major issue for health care systems in all countries. There are many contributing factors, including the use of antibiotics and the control of infection in our hospitals.

MRSA is part of the broader issue of antimicrobial resistance and this is being addressed in a number of ways. Guidelines for acute hospitals and other facilities on the control of MRSA were developed and circulated to health boards and other relevant parties in 1995. In 1999 a North-South study on MRSA prevalence was undertaken under the direction of the Eastern Regional Health Authority. This was a follow-up to a previous study carried out in 1995.

This study provided much useful data and also made a range of recommendations for the control of MRSA. These included identification of a wide range of issues which needed to be addressed at hospital level. The guidelines issued in 1995 suggest a variety of options for nursing patients with MRSA.

In 1999 my Department also asked the National Disease Surveillance Centre – NDSC – to evaluate the problem of antimicrobial resistance, including MRSA, in Ireland and to formulate a strategy for the future. The NDSC drew up a Strategy for the control of Antimicrobial Resistance in Ireland – SARI, which the Minister for Health and Children, Deputy Martin, launched on 19 June 2001. This report contains a wide range of detailed recommendations to address the issues which can be grouped into five categories, as follows: the surveillance of antimicrobial resistance; the monitoring of the supply and use of antimicrobials; the development of guidance in relation to the appropriate use of antimicrobials; education; and the development of principles in relation to infection control in the hospital and community setting.